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Abstract 
Previous studies have indicated that presynaptic -amino-3-hydroxy-5-methyl-4-
isoxazole propionate receptors (AMPARs) contribute to the regulation of 
neurotransmitter release. In hippocampal synapses, the presynaptic surface expression 
of several AMPAR subunits, including GluA2, is regulated in a ligand dependent 
manner. However, the molecular mechanisms underlying the presynaptic trafficking 
of AMPARs are still unknown. Here, using bright-field immunocytochemistry, 
western blots, and quantitative immunogold electron microscopy of the hippocampal 
CA1 area from intact adult rat brain, we demonstrate the association of AMPA 
receptors with the presynaptic active zone and with small presynaptic vesicles, in 
Schaffer collateral synapses in CA1 of the hippocampus. Furthermore, we show that 
GluA2 and protein interacting with C kinase 1 (PICK1) are colocalized at presynaptic 
vesicles. Similar to postsynaptic mechanisms, overexpression of either PICK1 or 
pep2m, which inhibit the N-ethylmaleimide sensitive fusion protein (NSF)-GluA2 
interaction, decreases the concentration of GluA2 in the presynaptic active zone 
membrane. These data suggest that the interacting proteins PICK1 and NSF act as 
regulators of presynaptic GluA2-containing AMPAR trafficking between the active 
zone and a vesicle pool that may provide the basis of presynaptic components of 
synaptic plasticity.   
 
 
Keywords: Synaptic plasticity, hippocampus, electron microscopy, AMPA, PICK1, 
receptor trafficking. 
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Introduction 
 
The majority of fast excitatory glutamatergic neurotransmission in the CNS is 
mediated by AMPARs that underpin cognitive processes like learning and memory 
(Derkach et al., 2007; Anggono and Huganir, 2012). Furthermore, AMPAR 
dysfunction underlies neurodegenerative diseases such as stroke and epilepsy (De 
Sarro et al., 2005; Kwak and Weiss, 2006; Bowie, 2008). AMPARs are assembled 
from subunits GluA1-4 into functional homo- or hetero-tetrameric cationic channels 
that are permeable to sodium and calcium (Hollmann and Heinemann, 1994; Bettler 
and Mulle, 1995; Traynelis et al., 2010). In the hippocampus, the majority of the 
AMPARs consist of the heteromers GluA1-GluA2 and GluA2-GluA3 (Wenthold et 
al., 1996). At the excitatory Schaffer collateral/commissural synapses onto CA1 
hippocampal pyramidal cells, about 80 % of postsynaptic AMPARs and >95 % of 
extrasynaptic AMPARs are GluA1-GluA2 heteromers, and most of the remaining 
receptors are GluA2-GluA3 heteromers (Lu et al., 2009). Thus, virtually all functional 
postsynaptic AMPARs in these synapses contain GluA2.  
 
The postsynaptic concentration of AMPARs is controlled by the equilibrium between 
insertion, removal and lateral diffusion of the plasma membrane receptors. These are 
highly regulated processes dependent on neuronal activity (Henley and Wilkinson, 
2016). Several synaptic proteins are involved in various steps of AMPAR regulation 
and trafficking, including PICK1, stargazin, postsynaptic density protein of 95 kDa 
(PSD-95), glutamate receptor interacting protein 1 (GRIP1), AMPAR binding protein 
(ABP), protein kinase C (PKC), and N-ethylmaleimide-sensitive factor (NSF) 
(Henley and Wilkinson, 2013).  
 
Although postsynaptic AMPARs are extensively studied neuronal proteins, the 
localization, trafficking and functions of presynaptic AMPARs is poorly understood. 
However, we and others have previously suggested that presynaptic AMPARs may 
function as autoreceptors, regulating neurotransmitter release (Patel and Croucher, 
1997; Schenk et al., 2003; Feligioni et al., 2006; Pittaluga et al., 2006; Haglerød et al., 
2009; Summa et al., 2011; Grilli et al., 2012). Intriguingly, we have also demonstrated 
that presynaptic AMPARs appear to be regulated in an opposite direction to the 
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postsynaptic receptors by AMPA and NMDA stimulation (Feligioni et al., 2006). 
Given the comparative paucity of information about presynaptic AMPARs we 
investigated if the same regulatory proteins that control postsynaptic AMPAR 
trafficking are also responsible for presynaptic AMPAR regulation. In particular we 
focused on PICK1 and NSF, both of which have well-characterized roles in the 
control of postsynaptic AMPARs. 
 
PICK1 interacts with both GluA2 and PKC at the postsynaptic site to regulate GluA2 
phosphorylation, thus altering its synaptic clustering, trafficking to neuronal surface 
and membrane recycling (Hastie, 2009). The interaction between PICK1 and GluA2 
is involved in the removal of GluA2 from the plasma membrane during long-term 
depression (LTD) in the hippocampus (Iwakura et al., 2001; Kim et al., 2001; Hanley 
and Henley, 2005) and the cerebellum (Xia et al., 2000; Steinberg et al., 2006; Hanley, 
2008; Terashima et al., 2008).  
 
NSF is an ATPase that is essential to provide the energy for presynaptic vesicular 
fusion events (Sollner et al., 1993) (Sudhof and Rizo, 2011). Intriguingly, NSF also 
plays a vital role at the postsynaptic membrane and is necessary for plasma membrane 
insertion of GluA2-containing AMPARs, increasing its surface expression (Huang et 
al., 2005; Araki et al., 2010). NSF binds the GluA2 C-terminus upstream of the PDZ 
binding site between residues Lys844 and Gln853. Disrupting NSF binding to GluA2 
decreases AMPAR mediated synaptic transmission (Nishimune et al., 1998; Song et 
al., 1998) and the surface expression of GluA2 (Noel et al., 1999). One way of 
impeding the NSF/GluA2 interaction is by introducing a peptide (pep2m) 
corresponding to the interaction site on GluA2 (Nishimune et al., 1998; Collingridge 
and Isaac, 2003; Evers et al., 2010). 
 
We have shown previously that PICK1 is present in the presynaptic terminal at 
concentrations comparable to those seen in postsynaptic spines (Haglerød et al., 2009). 
Inhibition of the interaction between PICK1 and GluA2 in rat hippocampal and 
cortical synaptosomal preparations alters AMPAR-mediated nor-adrenaline release 
(Pittaluga et al., 2006). Moreover, in the nucleus accumbens, presynaptic AMPARs 
have been reported to modulate nerve terminal dopamine release (Grilli et al., 2012). 
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To explore the relationship between presynaptic AMPARs and PICK1, we used 
western blotting and immunocytochemistry at light and electron microscopical levels 
to determine whether both proteins were present in the same neurons and in the same 
presynaptic terminals. We then used viral transduction of PICK1 or pep2m, a peptide 
that selectively inhibits NSF-GluA2 interactions, to determine the effects of 
increasing the presynaptic concentration of PICK1, or impeding the GluA2-NSF 
interaction, on the surface expression of GluA2.  
 
Our data provide evidence that PICK1 and NSF can act to regulate presynaptic 
trafficking of GluA2-containing AMPARs between a vesicle pool and the active zone.  
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Experimental procedures 
 
Antibodies 
The following primary antibodies were used: Anti-PICK1 (Abcam, Cambridge, UK, 
Cat# ab3420) was used at 1:10-1:15 for electron microscopy (EM) and 1:75 for light 
microscopy (LM). Anti-PICK1 (C100, from Jun Xia, Hong Kong) was used at 
1:1,500 for western blot (WB). Anti-GluA2 (Lifespan, Seattle, USA, Cat # LS-
B1473) was used at 1:5,000 for WB. Anti-GluA2 (Alomone labs, Jerusalem, Israel, 
Cat# AGC-005) was used at 1:75 for LM, and at 1:40 for EM. Anti-GluA2/3 
(Millipore, MA, USA, Cat# AB1506) was used at 1:30 for electron microscopy (EM). 
Anti-ß-tubulin (Tuj1) (Covance, CA, USA, MMS-435P) was used at 1:10,000 for WB. 
The following secondary antibodies were used: IgG coupled to 10 nm and 20 nm 
colloidal gold (British BioCell International, Cardiff, UK, Cat#R14007) was used at 
1:20-1:40 for EM. Goat anti-rabbit alkaline phosphatase (Sigma, MO, USA, 
Cat#A3687) was used at 1:10,000 for WB. Biotinylated goat anti-rabbit (Abcam, 
Cambridge, UK, Cat#Ab64256) was used at 1:100 together with a streptavidin 
biotinylated horseradish peroxidase complex (GE healthcare, Buckinghamshire, UK, 
Cat#RPN1051V) at 1:100 for light (LM). 
 
The selectivity of PICK1 antibody used in immunogold labeling is characterized 
previously (Haglerød et al., 2009). The anti-GluA2/3 antibody has been used in 
several recent immunocytochemical studies, which all have shown the expected 
characteristic staining pattern (Edwards et al., 2013; Sadeghi et al., 2014; Schuth et al., 
2014; Peng et al., 2015).  
 
Animals 
Wistar male rats weighing 250–300 g (Møllegaard, Ejby, Denmark) were used for 
EM and LM. PVG male rats, 2–4 months, (Scanbur, Nittedal, Norway), weighing 
200–250 g, were used for WB. The animals were allowed free access to food and 
water. Experimental protocols were approved by the Norwegian Institutional Animal 
Care and Use Committee and conform to National Institutes of Health guidelines for 
the care and use of animals. The organotypic cultures were prepared from p8 male 
Wistar rats, in accordance with British animal protection legislation and the British 
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National Committee for Ethics in Animal Research approved the experimental 
protocols. 
 
Immunocytochemistry 
Perfusion fixation: For electron microscopy, the rats (n=3) were deeply anaesthetized 
with Equithesin (0.4 ml/100 g body weight) followed by intracardiac perfusion with 
10-15 seconds flush of 4% Dextran-T70 in sodium phosphate buffer (pH 7.4) 
followed by a mixture of 4% FA and 0.1% GA in the same buffer. Small (0.5 x 0.5 
mm) blocks from CA1 were freeze substituted, sectioned, and immunolabeled as 
described previously (Mathiisen et al., 2006). For double labeling, the sections were 
first incubated with rabbit polyclonal anti-PICK1 followed by goat anti-rabbit coupled 
to 20 nm colloidal gold. The sections were exposed to formaldehyde vapor at 80 C for 
1 h and thereafter incubated with rabbit polyclonal anti-GluA2, followed by goat anti-
rabbit coupled to 10 nm colloidal gold. The sections were examined with a Fei Tecnai 
12 electron microscope at 60 kV. For bright field light microscopy the rats were 
perfused as above, but glutaraldehyde was omitted from the fixative. Vibratome 
sections were cut from whole brain tissue.  
 
Electron microscopy quantification and statistical analysis: Electron micrographs of 
asymmetric structurally defined synapses were obtained randomly from the middle 
layer of the stratum radiatum in the CA1 region of the hippocampus (Schaffer 
collateral synapses). Images of 60 synapses from each animal were selected for 
analysis; each showed intact plasma membranes, presynaptic vesicles and a clear 
synaptic cleft. GluA2 immunolabeling was quantified as number of gold particles/μm 
(linear density) of membrane length or as number of gold particles/μm2 (area density) 
for regions of interests in the intracellular compartment in asymmetric synapses. 
Specific plasma membrane and cytoplasmic compartments were defined as regions of 
interests (ROIs) and used for quantification. The ROIs were: the postsynaptic density 
membrane (PSD), the active zone (AZ), the postsynaptic lateral membrane (PoL), i.e., 
the plasma membrane on each side of the PSD, the presynaptic lateral membrane 
(PreL), i.e., the plasma membrane on each side of the active zone, the postsynaptic 
cytoplasm (PoCy), the presynaptic cytoplasm (PreCy), and the astrocyte cytoplasm 
(ACy). For all synapses, the synaptic lateral membranes were defined for convenience 
of measurement as equal to the length of the PSD, on both sides of the PSD or active 
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zone. An in-house extension to analySIS software connected with SPSS (SPSS Inc, 
Chicago, Illinois, USA) was used to evaluate the gold particle labeling of the specific 
plasma membrane and cytoplasmic compartments. The software calculated linear 
particle density (number per unit length of curve) over membrane domains and area 
particle density (number per unit area) over cytoplasmic compartments. In the first 
case, it measured the distance from each particle center to the membrane and included 
only those particles that were within an operator-defined distance from the curve 
segment. For plasma membranes the inclusion distance was symmetric between -21 
nm, and + 21 nm (negative signifying an intracellular location). In order to easily 
compare regions of interests, linear densities (particles/μm) were recalculated, using 
the inclusion distance from the middle of the plasma membrane, to area particle 
densities (particles/μm2). Data for particles were collected in ASCII files as flat tables 
and exported to SPSS for further statistical and graphical analysis. Note that in 
juxtaposed membranes, i.e., the active zone and postsynaptic density membrane 
(PSD), the inclusion zones partly overlap. Thus, the calculated gold particle density 
values for each of these two ROIs are somewhat overestimated.  
 
Organotypic slice cultures and viral infection 
Organotypic hippocampal slices were cultured according to the standard interface 
method (Stoppini et al., 1991). Transverse 350 μm thick hippocampal slices were 
prepared on a McIlwain tissue chopper (The Mickle Laboratory Engineering, UK) 
from p8 male Wistar rats under semi-sterile conditions. Each slice was transferred 
onto Millicell-CM membrane inserts (Millipore, MA, USA, Cat#PICM03050) and the 
cultures were maintained at 37o C humidified 95% air and 5% CO2. The culture 
media consisted of 75% minimal essential medium (MEM) (Thermo Fisher scientific, 
MA, USA) 25% heat inactivated horse serum (Gibco, Thermo Fisher) and glucose 
(6.5 g/l). The medium was changed twice a week. After 7 days, Sindbis virus 
containing inserts for green fluorescent protein (GFP), pep2m, or GFP-PICK1, was 
pressure injected using sterile Femtotips II microcapillaries (Eppendorf, Hamburg, 
Germany) mounted on an automated FemtoJet and InjectMan NI2 microinjection 
system (Eppendorf, Hamburg, Germany) into the CA1 pyramidal cell layer of each 
slice before being placed back into the incubator. The recombinant attenuated Sindbis 
viruses were produced as per manufacturers instructions (Invitrogen, Thermo Fisher). 
Briefly, RNA for Sindbis virus constructs (pSinRep5) encoding GFP, GFP-PICK1 
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and pep2m were prepared by in vitro translation and electroporated into BHK-21 
(baby hamster kidney cells) with DH26S (defective helper). Cells were spun down 
and supernatant containing pseudovirion was kept at -20 C until use. Slices were 
fixed 24 h after infection with 4% formaldehyde (FA) and 0.1 % glutaraldehyde (GA) 
in sodium phosphate buffer (pH 7.4). Small (0.5 x 0.5 mm) blocks from CA1 were 
freeze substituted, sectioned, and immunolabeled as described previously (Mathiisen 
et al., 2006). The cultures used in the present study were taken from a pool of cultures 
transfected for further immunofluorescence investigations. These confirmed the 
high efficiency of the virus infection. For subsequent immunogold quantifications it 
was impossible to monitor the transfection of the individual neurons or synapses. 
Thus, the selected pool of synapses would originate from both transfected and not 
transfected neurons. The resulting differences in labeling levels between transfected 
and non-transfected groups will then most likely be an underestimate, since non-
transfected synapses will be included in the transfected group as well. Three 
hippocampal slices from each group were used for analysis. Sixty profiles (20 profiles 
from each slice) from each region of interest were quantified. The ROIs used for 
quantification were: The postsynaptic density membrane (PSD), the active zone (AZ), 
the postsynaptic cytoplasm (PoCy) and the presynaptic cytoplasm (PreCy). 
 
Bright field microscopic studies 
Free floating vibratome sections from rat brain (50 µm) were treated with 1 M 
ethanolamine-HCL (pH 7.4), blocked with 3 % (v/v) normal calf serum (NCS) in 0.1 
M sodium phosphate buffer pH 7.4, and incubated with primary antibodies, overnight 
at room temperature (ON/RT), followed by incubation with secondary antibodies for 
1 hour at RT and development with the biotin-streptavidin-peroxidase system and 
3,3–Diaminobenzidine (DAB). 
 
Immunoblotting 
Four rats were sacrificed and different brain regions were dissected out. The 
homogenates of different brain regions were run on 4-20 % SDS-acrylamide gels, 
then electroblotted onto PVDF membrane (Hoefer Scientific Instruments, San 
Francisco, CA, USA) and immunostained with primary and secondary antibodies. The 
signal was detected by fluorescence using ECF substrate (Amersham biosciences, 
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UK). Quantitative analysis of blots was performed using Photoshop (Adobe) and 
Excel (Microsoft). Staining of different brain regions with anti-PICK1 and anti-
GluA2 were normalized against β-tubulin staining. Three blots for each protein were 
used for quantitation. A rectangular marker was made so that it could tightly fit the 
bands. Values for means and pixels were transferred to Excel sheet. The background 
was measured and subtracted from “mean”.  
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Results 
 
GluA2 and PICK1 are strongly, but differentially, expressed in synapse rich 
areas of the brain 
We reasoned that brain areas with the highest density of AMPARs and PICK1 would 
be most amenable to subsequent EM analysis of the ultrastructural localization of 
these proteins. Therefore, to determine relative levels of GluA2 and PICK1 in the 
brain, we performed quantitative western blot analysis of different rat brain regions. 
There are distinct differences in total GluA2 expression between different brain 
regions (Fig. 1B,D). The hippocampus clearly contains the highest concentration of 
GluA2, at 40% stronger mean band intensity than the cerebral cortex. The thalamus, 
brainstem and cerebellum show intermediate levels of GluA2, at 53%, 41%, and 60% 
of the cortex, respectively. The spinal cord shows only low GluA2 concentrations, at 
only 12% of the cortex.   
 
PICK1, however, is relatively uniformly expressed in the cortex, thalamus, and 
hippocampus, with the thalamus and hippocampus at 97% and 91% of the cerebral 
cortex, respectively (Fig. 1C,E). The brainstem and cerebellum showed intermediate 
levels of PICK1, at 74% and 86% of the cortex, respectively. The lowest 
concentration of the protein was found in the spinal cord, at 52% of the mean band 
intensity found in the cortex. Clearly, the variability of PICK1 expression among 
different brain regions is lower than that seen for GluA2.  
 
We next investigated the cellular distribution patterns of GluA2 and PICK1 in 
different brain regions. Bright field light microscopy (Fig. 2) revealed strong 
immunoreactivity for both PICK1 and GluA2 in the cerebral cortex, hippocampus, 
and thalamus (Fig. 2A1,A2,B1,B2), corresponding to our WB data. At higher 
magnifications, somata and proximal dendrites of cortical and hippocampal pyramidal 
cells, thalamic neurons and cerebellar Purkinje cells were all strongly immunopositive 
for both proteins, as were granule cells of the dentate gyrus (Fig. 2A3-8; 2B3-8), 
confirming the neuronal origin of the WB and immunohistochemical signal.  
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GluA2 and PICK1 are associated with presynaptic vesicles and the plasma 
membrane of the active zone in glutamatergic synapses 
Consistent with previous reports, our data confirm that the hippocampus strongly 
expresses both GluA2 and PICK1. Therefore, we used hippocampus for 
ultrastructural EM analyses of the presynaptic expression pattern of GluA2. We used 
postembedding immunogold labeling of thin sections of the middle levels of the 
stratum radiatum in the CA1 region of the hippocampus with anti-GluA2 antibody 
(Fig. 3A,C,D). Firstly, electron micrographs confirmed that GluA2 is present in 
postsynaptic spines, both in the postsynaptic density (PSD) region, and in the spine 
cytoplasm. Secondly, we observed the GluA2 subunit associated with the membrane 
of the active zone and in the presynaptic cytoplasm, associated with vesicles in 
asymmetric synapses. These were regarded as Schaffer-collateral synapses.  
 
We also performed postembedding immunolabeling of ultrathin sections with anti-
PICK1 antibody in the same area to determine the synaptic localization of this protein 
(Fig. 3B,C,D). Postsynaptically, PICK1 was associated with spine cytoplasm and the 
PSD. PICK1 was also present presynaptically, with gold particles associated with 
cytoplasm, vesicles and the active zone. Some gold particles were observed at 
perisynaptic lateral membranes, both pre and postsynaptically.  
 
Double immunogold labeling with anti-GluA2 and anti-PICK1 antibodies were 
performed to determine if PICK1 and GluA2 were colocalized in the same subcellular 
regions. Electron micrographs displayed the presence of GluA2 and PICK1 together 
in the same glutamatergic synapses (Fig. 3C,D). Both proteins were localized in pre- 
and postsynaptic vesicles in the same synapses. Colocalization of the proteins was 
also seen at the active zone (AZ) and the PSD. These results demonstrate that AMPA 
receptor GluA2 subunits are expressed in the presynaptic terminal as well as in the 
postsynaptic spine and colocalized with PICK1.  
 
Quantitative postembedding analysis of GluA2 expression in the synapse 
We subsequently performed an analysis of the number of GluA2-associated gold 
particles as a function of the distance from a line drawn through the centre of the 
synaptic cleft, between the pre- and postsynaptic plasma membranes (transverse 
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histogram). As is evident form Fig. 4B there was a large peak of gold particles 
associated with GluA2 over the PSD and the adjacent spine cytoplasm, and a 
somewhat smaller peak of gold particles over the active zone, with a low-value cleft 
between them, showing that GluA2 is present in both the synaptic plasma membranes.  
 
Next, we compared the GluA2 labeling intensities over different subsynaptic regions 
(see Fig. 4A for a schematic illustration of the different regions analyzed), through a 
quantitative distribution analysis of the gold particles. As is evident from Fig. 4C, the 
density of gold particles associated with GluA2 is high both in the PSD, where the 
mean number of gold particles per μm2 was 73, and in the active zone, where the 
mean number of gold particles per μm2 was 67. Thus, both the synaptic plasma 
membranes were clearly more strongly labeled for GluA2 than the plasma membranes 
lateral to the synaptic cleft: The lateral postsynaptic plasma membrane showed a 
mean number of gold particles per μm2 of 31, and the lateral presynaptic plasma 
membrane showed a mean number of gold particles per μm2 of 25.  
 
In the cytoplasmic compartments, the level of GluA2 presynaptic labeling (15 gold 
particles/μm2) is almost as high as in the corresponding postsynaptic cytoplasm (17 
gold particles/μm2), but both are clearly higher than in adjacent astrocytic cytoplasm 
(6 gold particles per μm2) (Fig. 4D). Thus, in addition to its established presence in 
postsynaptic spines, GluA2 appears to be associated with plasma- and vesicle 
membranes in presynaptic compartments of asymmetric synapses. 
 
Presynaptic trafficking of GluA2 is regulated by PICK1 and NSF 
To determine if PICK1 and NSF are involved in the trafficking of the AMPA receptor 
subunit GluA2 in presynaptic terminals, as established for postsynaptic spines, we 
performed viral infections of organotypic hippocampal cultures with pep2m and GFP-
PICK1, using separate infections with GFP as control. The peptide pep2m inhibits the 
interaction between GluA2 and NSF by binding to the NSF binding site on the C 
terminal of GluA2 (Nishimune et al., 1998; Noel et al., 1999; Collingridge and Isaac, 
2003). We immunolabeled ultrathin sections from each infection group with 
antibodies against GluA2/3 (Fig. 5A,B,C) and performed quantitative immunogold 
analysis of the PSD, active zone, and post- and presynaptic cytoplasm in the stratum 
radiatum of the CA1 region. The analysis (Fig. 5D,E) showed that in both 
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overexpressing PICK1 or blocking NSF-GluA2 interactions with pep2m significantly 
reduce GluA2/3 immunogold labeling within the PSD, the active zone and the 
postsynaptic cytoplasm compared with the control group (GFP). In the presynaptic 
cytoplasm, the GluA2/3 labeling intensity was only significantly reduced in the 
PICK1 group, suggesting that NSF involved in partitioning of AMPARs to the active 
zone but not their general recruitment and localization within the presynaptic bouton. 
Increasing the concentrations of PICK1 by transfection serves to decrease synaptic 
expressions of GluA2. Transfection with pep2m, presumably inhibiting the NSF-
GluA2 interaction, gives a similar result. 
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Discussion 
 
Synaptic plasticity can be regulated at the presynaptic side by altering the efficacy of 
neurotransmitter release (Bliss and Collingridge, 1993; Bear and Malenka, 1994; 
Lisman, 2003; Enoki et al., 2009; Anggono and Huganir, 2012; Choquet and Triller, 
2013). For a functional presynaptic regulation, one would expect both feedforward 
and feedback mechanisms in order to adjust the strength of neurotransmission. One 
way of achieving such a feedback function in synapses would be to insert AMPA 
receptors also in the presynaptic plasma membrane, acting as glutamate sensors. 
 
The underlying question behind the present investigation is whether suitable synaptic 
feedback mechanisms are in place to sustain regulation of presynaptic release, in this 
case in the Schaffer collateral synapses in CA1 in the hippocampus. Specifically, this 
entails the presence of autoreceptors on the presynaptic plasma membrane, providing 
continuous information back to the terminal about the concentration of transmitter in 
the synaptic cleft. However, it will also necessitate molecular means of regulating the 
sensitivity of the presynaptic autoreceptor apparatus. An effective way of doing this is 
by increasing or decreasing the concentration of the autoreceptors in the presynaptic 
active zone.  
 
We have investigated AMPAR localization within the presynaptic plasma membrane, 
by using antibodies against the AMPA receptor subunit GluA2. We found that GluA2 
is present in the active zone, thereby providing a means of monitoring glutamate 
concentration in the synaptic cleft, and we found that presynaptic terminals also 
contain PICK1, which could provide a mechanism for regulating the concentration of 
GluA2 in the active zone. Different physiological functions of presynaptic glutamate 
receptors have been discussed previously (Pinheiro and Mulle, 2008). However, the 
presynaptic functions and mechanisms have been technically challenging to 
investigate. At the calyx of Held, in the rat auditory brainstem, activation of 
presynaptic AMPA receptors have been shown to induce inward currents in the nerve 
terminal and thus inhibit presynaptic Ca2+ currents, thereby attenuating glutamatergic 
synaptic transmission (Takago et al., 2005). 
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In the experiments used for quantification (Figs. 4, 5) we used an antibody that does 
not distinguish between GluA2 and GluA3. Thus, we cannot exclude that some of the 
quantified gold particles in fact represent GluA3 subunits. However, as referred to in 
the introduction, the vast majority of synaptic and extrasynaptic AMPA receptors 
contain GluA2, only a minority contains GluA3, and of these, most are GluA2-GluA3 
heteromers. We also tested the presynaptic localization of GluA2 with a specific 
antibody (Fig. 3), clearly showing the presence of GluA2 in presynaptic terminals. 
Thus, the contribution of GluA3 subunits to our results should for all practical 
purposes be small. 
 
Initially we used western blotting (Fig. 1) and light microscopical 
immunohisto/cytochemistry (Fig. 2) to confirm the presence of GluA2 and PICK1 in 
neurons of various brain regions. While these methods did not enable us to distinguish 
between pre- and postsynaptic receptors, they did show us that compared to various 
brain regions, the hippocampus is enriched in GluA2 and PICK1. Our regional GluA2 
results were consistent with previous studies (Petralia and Wenthold, 1992; Martin et 
al., 1993) but, to our knowledge, this is the first work that compares PICK1 levels in 
different brain regions in a quantitative manner. 
 
High concentrations of AMPA receptors may be expected in areas of the brain with 
high demands for synaptic plasticity, like the hippocampus. On the other hand, as is 
evident from the light microscopical immunocytochemical staining experiments (Fig. 
2A), most of the expressed GluA2 protein is localized within the intracellular 
somatic/dendritic cytoplasm, and not in the synapses. The synaptic pool of GluA2, 
specifically, is more relevant for discussing the functional role of the receptor subunit 
than the overall hippocampal or brain concentration.  
 
In the main part of our study, we then used quantitative, high-resolution immunogold 
electron microscopy to investigate subsynaptic concentrations of GluA2 and PICK1, 
and also the interplay between these two proteins in the pre- and postsynaptic 
compartments, in addition to the role of NSF in these regulatory processes. The 
immunogold labeling patterns (Fig. 3 and 4) confirm that GluA2 is present 
presynaptically as well as postsynaptically. There are minor differences between the 
densities of GluA2 gold particles in the PSD vs the AZ and the postsynaptic 
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cytoplasm vs the presynaptic cytoplasm. On the other hand, both the synaptic plasma 
membrane regions have remarkable higher densities of GluA2 gold particles than the 
parts of the membranes lateral to the PSD or AZ. These observations are entirely 
consistent with presynaptic AMPAR functions. Interestingly, although astrocytes 
have been shown to express functional AMPARs (Seifert and Steinhauser, 2001; 
Dzamba et al., 2015), we show here that the concentration of AMPA receptors in 
astrocytes is only about a third of that found in neuronal synapses.  
 
We have previously reported the presence of GluA2 in presynaptic terminals in the 
CA1 region of the hippocampus (Feligioni et al., 2006; Haglerød et al., 2009). Several 
others have reported the presence of presynaptic AMPARs in other CNS synapses 
(Satake et al., 2000; Schenk et al., 2003; Takago et al., 2005; Chavez et al., 2006; 
Pittaluga et al., 2006; Summa et al., 2011; Grilli et al., 2012). However, this is the 
first quantitative analysis of the intrasynaptic distribution of this AMPAR subunit. 
Most importantly, we show that the concentrations of presynaptic pools of GluA2 are 
comparable to those of the postsynaptic spine, and that the active zone harbors 
significant concentrations of this AMPAR subunit. The presence of GluA2 in the 
presynaptic active zone and cytoplasm is compatible with the hypothesis that GluA2 
functions as a presynaptic autoreceptor to modulate transmitter release. In an 
influential analysis of the protein content of synaptic vesicles (Takamori et al., 2006), 
neither GluA2, GluA3, or PICK1 are mentioned. However, this study used a synaptic 
vesicle preparation from whole rat brain, and the proteins were found by Coomassie 
blue staining after gel electrophoresis. If presynaptic AMPA receptors only occur in a 
subset of synapses, there would be little chance of identifying them with Coomassie 
blue from a whole brain. 
 
We also confirm (Haglerød et al., 2009) that PICK1 co-localizes at the ultrastructural 
level with GluA2 (Fig. 3C,D). Both proteins are present on pre- and postsynaptic 
vesicles, in many cases the same vesicles. Furthermore, our data show that 
overexpression of PICK1 and pep2m significantly reduces the immunogold labeling 
intensity of GluA2 over synaptic membranes (Fig. 5). These data are consistent with 
the possibility that PICK1 and NSF interact with, and regulate the local trafficking of 
GluA2 in presynaptic terminals, as they have been shown to do postsynaptically 
(Anggono and Huganir, 2012; Henley and Wilkinson, 2013). More specifically, our 
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data are compatible with a model where PICK1 facilitates internalization of GluA2, 
from the active zone to the intracellular pool, while NSF facilitates insertion of GluA2 
from the intracellular pool to the active zone. We have previously shown GluA2- and 
PICK1-staining of synaptic vesicle fractions (Haglerød et al., 2009), but we still 
cannot exclude that some of the immunogold labeling seen in the present 
investigation could represent endosomes or other presynaptic organelles. 
 
The expression of GluA2 within the active zone ensures proximity to sites of 
vesicular release. Upon release of transmitter from a single vesicle, the concentration 
of glutamate within the synaptic cleft may by some estimates, about 1 mM (Clements 
et al., 1992), be sufficiently high to activate all the AMPA receptors within the 
membrane of the presynaptic active zone. One study has in fact provided support for 
presynaptic AMPA receptors providing a positive feedback system at presynaptic, 
glutamatergic synapses that could play important roles in plasticity as well as in 
excitotoxic processes (Patel and Croucher, 1997). 
 
At the postsynaptic site, both PICK1 and NSF contribute to regulating GluA2 
insertion and retraction from the plasma membrane in a calcium dependent manner 
(Hanley and Henley, 2005). Our data suggest that PICK1 and NSF may play a similar 
role in the presynaptic terminal, where overexpression of PICK1, as well as 
expression of pep2m, reduces the labeling intensity of GluA2 at plasma membrane 
and cytoplasmic sites. The reduction in labeling intensity over cytoplasmic areas may 
reflect retrograde transport of the receptors from the terminal after retraction from the 
plasma membrane. 
 
The absolute number of synaptic gold particles obtained with GluA2/3 antibody was 
higher in the organotypical cultures than in intact brain tissue (Fig. 5 vs Fig. 4). The 
difference was more strongly pronounced in the plasma membrane compartments 
(PSD and AZ) than in the cytoplasmic compartments. The main reason for the 
difference is probably that these tissues were treated very differently with regard to 
fixation procedures, but also that the intact brain sections and the organotypical 
sections were labeled in different experiments. However, due to the different ages of 
the animals, as well as the difference between intact brain and cultures, there may be a 
real difference in the intrasynaptic distribution between plasma membrane and 
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cytoplasmic AMPA receptor pools.   
 
The technical challenges with transfecting the pre- and postsynaptic elements in 
separate experiments were greater than we were able to successfully attack in the 
present investigation. The Schaffer collateral axons pass through the CA1 area to 
terminate on the pyramidal cell apical dendrites. The consequence is that virus that is 
injected into the stratum pyramidale can also transfect axons passing through this area. 
The distance from the injection site to the synapses we have investigated is only about 
100 m. Axons and terminals harbor the molecular machinery necessary for local 
protein synthesis (Crispino et al., 2014), so that by virus injection at a single site, the 
proteins were expressed in both the pre- and postsynaptic elements.   
 
According to our hypothesis that presynaptic AMPA receptors have a role as 
autoreceptors on the extracellular side of the synaptic plasma membrane, the ligand-
bidning site will then be localized on the luminal side of the corresponding synaptic 
vesicles. These vesicles contain high concentrations of glutamate. However, due to 
the rapid desensitization and closing of AMPA receptors after binding of glutamate 
(Jones and Westbrook, 1996), we would expect little leakage of ions from the vesicles 
through the receptor channels. 
 
One obvious intriguing question is whether the GluA2/PICK1-associated presynaptic 
vesicles represent a distinct sub-pool of vesicles in the terminal, or whether they are 
identical to the glutamate containing vesicles that are used for neurotransmitter 
release. We do not have any data that may answer this question. The possibility exists 
then, that upon vesicular glutamate release, glutamate receptors are simultaneously 
and automatically inserted into the presynaptic plasma membrane along the active 
zone. On the other hand, if GluA2 is present on a subset of presynaptic vesicles, there 
might exist distinct exocytotic regulatory mechanisms for these vesicles, independent 
of transmitter release itself. Further studies are needed to determine between these 
alternatives.  
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Figure legends 
 
Fig. 1. Western blots of homogenates from different brain regions, i.e., cortex [Cx], 
thalamus [Th], hippocampus [Hc], brain stem [Bs], cerebellum [Cb], and spinal cord 
[Spc]. (A) Staining of different brain regions were normalized against β-tubulin 
staining. (B) Staining with anti-GluA2. (C) Staining with anti-PICK1. (D) 
Quantitation of GluA2 labeling intensities. (E) Quantitation of PICK-1 labeling 
intensities. Error bars denote SEM, (n = 3).   
 
Fig. 2. Light micrographs of rat brain vibratome sections, stained with 
immunoperoxidase method, with anti-GluA2 (A) and anti-PICK1 (B). The upper left 
image in each of the panels is coronal sections showing cortex, hippocampus, and 
thalamus. Hc: hippocampus. CA1, CA3 and DG (dentate gyrus) are subregions of the 
hippocampus. Cx: cerebral cortex. Th: thalamus. Cb: cerebellum. Note neurons with 
dense staining throughout the cytoplasm and large dendrites. Scale bars: Brain 2 mm. 
Hc 500 μm. CA1, CA3, DG, Th 20 μm. Cx 50 μm. Cb 25 μm.  
 
Fig. 3. Electron micrographs of asymmetric synapses in the stratum radiatum in CA1 
of the hippocampus. Immunogold labeling with anti-GluA2 (A) and anti-PICK1 (B). 
(C,D) Double immunogold labeling for PICK1 (20 nm) and GluA2 (10 nm). Note 
labeling of pre- and postsynaptic vesicles. Abbreviations: AT, axon terminal; PS, 
postsynaptic; AZ, active zone; PSD, postsynaptic density. Scale bars:  A, B, C: 125 
nm. D: 50 nm.  
 
Fig. 4. Quantification of immunogold localization after GluA2/3 labeling in different 
subcellular compartments of asymmetric stratum radiatum synapses in CA1 of the 
hippocampus. (A) Schematic illustration of a synapse, with seven specific membrane 
or cytoplasmic compartments that were subjected to quantitative analysis of gold 
particle labeling: postsynaptic density membrane (PSD), active zone (AZ), 
postsynaptic lateral membrane (PoL), presynaptic lateral membrane (PreL), 
postsynaptic cytoplasm (PoCy), presynaptic cytoplasm (PreCy), and astrocyte 
cytoplasm (ACy). The length of the lateral membranes included for quantification 
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correspond to half of the total length of the PSD or the active zone on each side. (B) 
Transverse histogram showing the number of gold particles at different distances (nm) 
from the middle of the synaptic cleft (zero), in postsynaptic (negative values), and 
presynaptic (positive values) directions, respectively. The histogram shows that the 
immunogold particles are strongly concentrated over the postsynaptic density, while a 
slightly lower immunogold labeling is seen over the active zone. (C) Quantitative 
assessment of labeling density over four different plasma membrane compartments 
indicated in A. (D) Quantitative assessment of labeling area density in three different 
cytoplasmic membrane compartments indicated in A. Values along the abscissa gives 
the density of gold particles/m2 ± 95% confidence interval in C and D (n = 60). 
 
Fig. 5. Quantitative immunogold analysis of GluA2/3 labeling intensity of 
asymmetric synapses in stratum radiatum of organotypic cultures of the hippocampus 
(CA1 region) virally infected with PICK1, pep2m and GFP (control). (A-C) Electron 
micrographs showing immunogold labeling of synapses infected with (A) GFP, (B) 
pep2m, (C) PICK1. (D) Analysis of gold area density (number of gold particles/μm2) 
was performed over the postsynaptic density (PSD) and the active zone (AZ). (E) 
Analysis of gold particle area density (number of gold particles/μm2) was performed 
over the postsynaptic cytoplasm (PoCy), and the presynaptic cytoplasm (PreCy). Note 
that the labeling intensity was significantly reduced in both transfection groups, i.e. 
PICK1 (white bars) and pep2m (light grey bars), compared to the control (dark grey 
bars) over the postsynaptic density, the presynaptic active zone and the postsynaptic 
cytoplasm. In the presynaptic cytoplasm the labeling intensity was only significantly 
reduced in the PICK1 group. Statistical significance (p<0.05) indicated with an 
asterisk. Error bars show 95% confidence interval (CI) (n = 60). Scale bars: 200 nm.   
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